ストックスクリーナーアプリを入手
0.6697
2.94%
-0.0203
プレマーケット:
.72
0.0503
+7.51%
前日終値:
$0.69
開ける：
$0.7253
24時間の取引高:
309.21K
Relative Volume:
0.84
時価総額：
$32.55M
収益：
$1.14M
当期純損益:
$-60.82M
株価収益率:
-0.5021
EPS:
-1.3338
ネットキャッシュフロー:
$-60.29M
1週間 パフォーマンス:
-9.50%
1か月 パフォーマンス:
-33.69%
6か月 パフォーマンス:
-45.11%
1年 パフォーマンス:
-29.39%
1日の値動き範囲:
$0.6616
$0.7253
1週間の範囲:
$0.6616
$0.75
52週間の値動き範囲:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.6697 | 32.55M | 1.14M | -60.82M | -60.29M | -1.3338 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
Werewolf Therapeutics (ticker: HOWL) holders detail stake and sales in 13D/A - Stock Titan
How Werewolf Therapeutics (HOWL) earnings power compares to its price (Mini Selloff) 2026-05-05Fundamentals - Newser
Werewolf Therapeutics director Luke Evnin sells $198,309 in shares - Investing.com
Werewolf Therapeutics (NASDAQ: HOWL) entities sell 274K shares - Stock Titan
Werewolf Therapeutics (HOWL) price target increased by 12.00% to 7.14 - MSN
Werewolf Therapeutics director Luke Evnin sells $154,525 in stock - Investing.com
Werewolf Therapeutics (HOWL) stake trimmed by MPM entities in planned sales - Stock Titan
[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan
MSN Money - MSN
Werewolf Therapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
HOWL Price Today: Werewolf Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Werewolf Therapeutics (HOWL) Stock Bid Wall (Smart Money Exits) 2026-04-20Swing Signals - Newser
HOWL Forecast, Price Target & Analyst Ratings | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
Geopolitics Watch: Does Werewolf Therapeutics Inc have consistent dividend growthExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Werewolf Therapeutics (NASDAQ:HOWL) Raised to “Hold” at Wall Street Zen - Defense World
HOWL Technical Analysis & Stock Price Forecast - Intellectia AI
HOWL Should I Buy - Intellectia AI
Investment Report: Is now the right time to enter Werewolf Therapeutics IncWeekly Trend Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price - TipRanks
HOWL PE Ratio & Valuation, Is HOWL Overvalued - Intellectia AI
Aug Action: Is now the right time to enter Werewolf Therapeutics Inc2026 Technical Patterns & Accurate Buy Signal Alerts - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - bitget.com
Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - tipranks.com
Werewolf Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings - AlphaStreet
Werewolf Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Werewolf Therapeutics Reports 2025 Financial Results and Advances Cancer Therapy Clinical Pipeline - geneonline.com
Werewolf Therapeutics (HOWL) faces going‑concern risk while IL‑2 and IL‑12 candidates show early responses - Stock Titan
Werewolf Therapeutics 10-K: Revenue $0M, Net Loss $(60.82)M - TradingView
Earnings Scheduled For March 27, 2026 - Benzinga
HOWL: Strategic review underway with improved financials and continued progress in oncology pipeline - tradingview.com
Werewolf Therapeutics (NASDAQ: HOWL) cuts 2025 loss and launches strategic review - Stock Titan
Aug Drivers: Is Werewolf Therapeutics Inc a speculative investment2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Biotech 'Lowballed' Landlord On Lease Exit, Suit Says - Law360
Werewolf Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
HOWL Stock Price, Quote & Chart | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Michael J. Urban Net Worth (2026) - GuruFocus
Werewolf Therapeutics (HOWL) eyes 2026 catalysts following FDA guidance and encouraging INDUKINE results - MSN
RSI Check: Is Werewolf Therapeutics Inc stock trending bullishTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Analyst Downgrade: Is now the right time to enter Werewolf Therapeutics IncLayoff News & Real-Time Volume Triggers - baoquankhu1.vn
Werewolf Therapeutics (HOWL) finance VP reports stock and option holdings on Form 3 - Stock Titan
Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN
Werewolf Therapeutics (HOWL) Stock Analysis Report | Financials & Insights - Benzinga Japan
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Published on: 2026-03-05 15:55:35 - baoquankhu1.vn
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits
HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):